_PRIVATE_LIMITED.webp)
Cure Medicines (India) Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
- Paid Up Capital ₹ 3.00 M
- Company Age 21 Year, 10 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 8.00 Cr
- Satisfied Charges ₹ 1.50 Cr
- Revenue Growth -42.32%
- Profit Growth -510.92%
- Ebitda -292.70%
- Net Worth -26.56%
- Total Assets 25.89%
About Cure Medicines (India)
Cure Medicines (India) Private Limited (CMIPL) is a Private Limited Indian Non-Government Company incorporated in India on 26 March 2003 and has a history of 21 years and ten months. Its registered office is in Pune, Maharashtra, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 3.00 M.
The company currently has active open charges totaling ₹8.00 Cr. The company has closed loans amounting to ₹1.50 Cr, as per Ministry of Corporate Affairs (MCA) records.
Shyam Bothikar and Ulhas Puranik serve as directors at the Company.
Company Details
- Location
Pune, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media-
Corporate Identity Details
- CIN/LLPIN
U24230PN2003PTC140047
- Company No.
140047
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
26 Mar 2003
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Pune
Industry
Who are the key members and board of directors at Cure Medicines (India)?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Shyam Bothikar  | Director | 15-Mar-2007 | Current |
| Ulhas Puranik | Director | 15-Mar-2007 | Current |
Financial Performance of Cure Medicines (India).
Cure Medicines (India) Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 42.32% decrease. The company also saw a substantial fall in profitability, with a 510.92% decrease in profit. The company's net worth observed a substantial decline by a decrease of 26.56%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Cure Medicines (India)?
In 2023, Cure Medicines (India) had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Cure Laboratories Private LimitedShyam Bothikar and Ulhas Puranik are mutual person
Cure Exports Private LimitedShyam Bothikar and Ulhas Puranik are mutual person
Sava Healthcare LimitedUlhas Puranik is a mutual person
Dignity Healthcare Private LimitedShyam Bothikar is a mutual person
- Avet Lifesciences Private Limited
Ulhas Puranik is a mutual person
- Optimus Medtech Private Limited
Ulhas Puranik is a mutual person
Charges (Loans)
₹80.00 M
₹15.00 M
Charges Breakdown by Lending Institutions
- Others : 8.00 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 30 Mar 2024 | Others | ₹5.00 Cr | Open |
| 11 Nov 2022 | Others | ₹8.50 M | Open |
| 15 Oct 2022 | Others | ₹1.50 M | Open |
| 13 Aug 2003 | Others | ₹2.00 Cr | Open |
| 07 Jul 2017 | Others | ₹5.00 M | Satisfied |
How Many Employees Work at Cure Medicines (India)?
Cure Medicines (India) has a workforce of 42 employees as of Apr 01, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Cure Medicines (India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Cure Medicines (India)'s trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
